The role of particle size of glyburide crystals in improving its oral absorption-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The role of particle size of glyburide crystals in improving its oral absorption

Published:2017-03-31 Issue:3 Volume:7 Page:428-438
ISSN:2190-393X
Container-title:Drug Delivery and Translational Research
language:en
Short-container-title:Drug Deliv. and Transl. Res.

Author:

Wang Yongjun,Yang Wenqian,Fu Qiang,Guo Zhibin,Sun Bingjun,Liu Wen,Liu Yaxuan,Mu Simeng,Guo Mengran,Li Jingru,Pu Xiaohui,He Zhonggui

Funder

for Fostering Talents in Basic Science

National Nature Science Foundation of China

Doctoral Research Funding of Liaoning Province

General Project in Education Department of Liaoning Province

Scientific Research Foundation

Publisher

Springer Science and Business Media LLC

Subject

Pharmaceutical Science

Link

http://link.springer.com/content/pdf/10.1007/s13346-017-0378-3.pdf

Reference43 articles.

1. Cooper ER. Nanoparticles: a personal experience for formulating poorly water soluble drugs. Journal of controlled release : official journal of the Controlled Release Society. 2010;141(3):300–2. doi: 10.1016/j.jconrel.2009.10.006 .

2. Gao L, Liu G, Ma J, Wang X, Zhou L, Li X. Drug nanocrystals: in vivo performances. Journal of controlled release : official journal of the Controlled Release Society. 2012;160(3):418–30. doi: 10.1016/j.jconrel.2012.03.013 .

3. Kesisoglou F, Panmai S, Wu Y. Nanosizing—oral formulation development and biopharmaceutical evaluation. Adv Drug Deliv Rev. 2007;59(7):631–44. doi: 10.1016/j.addr.2007.05.003 .

4. Khadka P, Ro J, Kim H, Kim I, Kim JT, Kim H, et al. Pharmaceutical particle technologies: an approach to improve drug solubility, dissolution and bioavailability. Asian Journal of Pharmaceutical Sciences. 2014;9(6):304–16. doi: 10.1016/j.ajps.2014.05.005 .

5. Sigfridsson K, Lundqvist AJ, Strimfors M. Particle size reduction and pharmacokinetic evaluation of a poorly soluble acid and a poorly soluble base during early development. Drug Dev Ind Pharm. 2011;37(3):243–51. doi: 10.3109/03639045.2010.505927 .

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Improving Riparin-A Dissolution through a Laponite Based Nanohybrid;Pharmaceutics;2023-08-14

2. Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs;Life;2023-04-27

3. The Rat Continuous Intestine Model Predicts the Impact of Particle Size and Transporters on the Oral Absorption of Glyburide;Molecular Pharmaceutics;2022-12-21

4. Supramolecular aggregates of myricetin improve its bioavailability and its role in counteracting alcoholism;Journal of Drug Delivery Science and Technology;2022-08

5. Glibenclamide-Loaded Polyvinylpyrrolidone (PVP) Nanoparticles and Glibenclamide-Loaded Soluplus® Nanomicelles Intended for Parenteral Administration: Effect of Solvents Mixtures on the Electrosprayed Nanoparticles and In vitro Characterization;Journal of Pharmaceutical Research International;2021-12-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3